.png){kind=spacer}
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Scaling clinico-genomic data integration: Large pharmaceutical organizations working with external data providers used Polly to build interoperable clinico-genomic data products 6x faster.
Although purchased datasets are often labeled as "clean," they still lack interoperability—Polly's pipelines bridge this gap with robust integration and harmonization.
Information Retrieval: Drug safety monitoring teams used Polly's Knowledge Graph powered co-scientist to conversationally retrieve the right cohorts & assess drug response—cutting discovery time by 70%.
%201.svg){kind=icon}
If you’re working with complex biological data, you may be asking:
Can generative AI truly assist in scientific reasoning, not just data analysis?
What does it mean for hypothesis generation, literature review, or even designing experiments?
Could this accelerate—not replace—my discovery pipeline?
Whether you're skeptical, curious, or already experimenting with AI in your lab—this is a session designed to ground your understanding in evidence, not speculation.
.svg)
.svg)
%201%20(1).svg)
.svg)
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.webp)
.webp)
.webp){kind=spacer}
.webp){kind=spacer}
.webp)
.webp)
.webp)
.webp){kind=spacer}
.webp)
.webp)
.webp)
.webp)
.webp)
.svg)
%20(1).svg)
